Psoriatic Arthritis and Arthritis - Yahoo Search Results

- Psoriatic arthritis vs. reactive arthritis: Comparison
  Medical News Today· 5 days ago
  Psoriatic arthritis (PsA) and reactive arthritis (ReA) are different types of arthritis. PsA is a...
- What's the difference between psoriatic arthritis and Crohn's disease?
  Medical News Today· 1 week ago
  Psoriatic arthritis (PsA) and Crohn’s disease are inflammatory conditions that affect the joints and...
- Does psoriatic arthritis cause hair loss? Risks and tips
  Medical News Today· 6 days ago
  Psoriatic arthritis (PsA) causes higher levels of inflammation in the body, which can cause stress...
- Psoriatic arthritis: Lifestyle changes that help
  Medical News Today· 6 days ago
  Psoriatic arthritis (PsA) is a progressive inflammatory disease that may develop in people with psoriasis. Lifestyle changes can help manage PsA symptoms...
- Psoriatic arthritis vs. MS: Symptoms, links, and more
  Medical News Today· 6 days ago
  Psoriatic arthritis and MS are both autoimmune conditions. Learn more about the possible links...
- Arthritis: Watch out for these symptoms
  MSN News· 2 weeks ago
  Characterized by inflammation in the joints or other areas of the body, arthritis is thought to affect more than a billion people worldwide. This is...
- Patients struggle to get Methotrexate after Roe v. Wade reversal, health experts say
  WTSP-TV Tampa· 22 hours ago
  Anyone experiencing difficulty getting their prescriptions filled can report the issue to multiple...
- Arthritis Pain Is Real! Here's How Two Patients Deal With Inflammatory and Osteoarthritis
  Parade· 4 days ago
  Elaine Husni, M.D., vice chair and director of the Department of Rheumatic and Immunologic Diseases...
- Midfoot arthritis: Symptoms, causes, and treatment
  Medical News Today· 6 days ago
  Midfoot arthritis is joint inflammation that impacts the middle of the foot. People can develop midfoot arthritis for various reasons. It may occur due ...
- CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active...
  WDTN-TV 2 Dayton· 1 week ago
  CHMP positive opinion is based on results from the Phase 3 SELECT-AXIS 2 study showing upadacitinib (RINVOQ®) met the primary endpoint of ASAS40 response at week 14 versus placebo1Non-radiographic axial spondyloarthritis (nr-axSpA) is part